{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:06:25Z","timestamp":1773799585980,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009053","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000}}],"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM012222"],"award-info":[{"award-number":["R01LM012222"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM012222"],"award-info":[{"award-number":["R01LM012222"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM012482"],"award-info":[{"award-number":["R01LM012482"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM012482"],"award-info":[{"award-number":["R01LM012482"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM140635"],"award-info":[{"award-number":["R01GM140635"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R01GM140635"],"award-info":[{"award-number":["R01GM140635"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Drug-drug interactions account for up to 30% of adverse drug reactions. Increasing prevalence of electronic health records (EHRs) offers a unique opportunity to build machine learning algorithms to identify drug-drug interactions that drive adverse events. In this study, we investigated hospitalizations\u2019 data to study drug interactions with non-steroidal anti-inflammatory drugs (NSAIDS) that result in drug-induced liver injury (DILI). We propose a logistic regression based machine learning algorithm that unearths several known interactions from an EHR dataset of about 400,000 hospitalization. Our proposed modeling framework is successful in detecting 87.5% of the positive controls, which are defined by drugs known to interact with diclofenac causing an increased risk of DILI, and correctly ranks aggregate risk of DILI for eight commonly prescribed NSAIDs. We found that our modeling framework is particularly successful in inferring associations of drug-drug interactions from relatively small EHR datasets. Furthermore, we have identified a novel and potentially hepatotoxic interaction that might occur during concomitant use of meloxicam and esomeprazole, which are commonly prescribed together to allay NSAID-induced gastrointestinal (GI) bleeding. Empirically, we validate our approach against prior methods for signal detection on EHR datasets, in which our proposed approach outperforms all the compared methods across most metrics, such as area under the receiver operating characteristic curve (AUROC) and area under the precision-recall curve (AUPRC).<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009053","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T17:41:56Z","timestamp":1625593316000},"page":"e1009053","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3543-3829","authenticated-orcid":true,"given":"Arghya","family":"Datta","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8542-8887","authenticated-orcid":true,"given":"Noah R.","family":"Flynn","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5048-2982","authenticated-orcid":true,"given":"Dustyn A.","family":"Barnette","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6385-3970","authenticated-orcid":true,"given":"Keith F.","family":"Woeltje","sequence":"additional","affiliation":[]},{"given":"Grover P.","family":"Miller","sequence":"additional","affiliation":[]},{"given":"S. Joshua","family":"Swamidass","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"1","key":"pcbi.1009053.ref001","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.synbio.2018.10.002","article-title":"Synergistic drug combinations prediction by integrating pharmacological data","volume":"4","author":"C Zhang","year":"2019","journal-title":"Synthetic and Systems Biotechnology"},{"key":"pcbi.1009053.ref002","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations improve therapeutic selectivity","volume":"27","author":"J Lehar","year":"2009","journal-title":"Nature biotechnology"},{"key":"pcbi.1009053.ref003","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fphar.2018.00535","article-title":"Searching Synergistic Dose Combinations for Anticancer Drugs","volume":"9","author":"Z Yin","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"pcbi.1009053.ref004","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23321-6","article-title":"CISNE: An accurate description of dose-effect and synergism in combination therapies","volume":"8","author":"A Garcia-Fuente","year":"2018","journal-title":"Scientific Reports"},{"issue":"2","key":"pcbi.1009053.ref005","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fshw.2019.01.003","article-title":"Mathematical rules for synergistic, additive, and antagonistic effects of multi-drug combinations and their application in research and development of combinatorial drugs and special medical food combinations","volume":"8","author":"S Yuan","year":"2019","journal-title":"Food Science and Human Wellness"},{"key":"pcbi.1009053.ref006","volume-title":"Drug-Drug Interactions","author":"M Rowland","year":"2008","edition":"2"},{"issue":"1","key":"pcbi.1009053.ref007","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-017-0621-2","article-title":"What is polypharmacy? A systematic review of definitions","volume":"17","author":"N Masnoon","year":"2017","journal-title":"BMC Geriatr"},{"issue":"669","key":"pcbi.1009053.ref008","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.3399\/bjgp18X695465","article-title":"The epidemiology of multimorbidity in primary care: a retrospective cohort study","volume":"68","author":"A Cassell","year":"2018","journal-title":"British Journal of General Practice"},{"issue":"1","key":"pcbi.1009053.ref009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in Older Adults","volume":"35","author":"ME Salive","year":"2013","journal-title":"Epidemiologic Reviews"},{"issue":"23","key":"pcbi.1009053.ref010","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"RB Mokhtari","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"pcbi.1009053.ref011","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1001\/jamainternmed.2015.8581","article-title":"Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011","volume":"176","author":"DM Qato","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"2","key":"pcbi.1009053.ref012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1086-5802(16)31229-3","article-title":"Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness Model","volume":"41","author":"FR Ernst","year":"2001","journal-title":"Journal of the American Pharmaceutical Association (1996)"},{"issue":"7","key":"pcbi.1009053.ref013","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2174\/138920006778520598","article-title":"In vivo animal models for investigating potential CYP3A- and Pgp-mediated drug-drug interactions","volume":"7","author":"PH Marathe","year":"2006","journal-title":"Current drug metabolism"},{"key":"pcbi.1009053.ref014","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1208\/s12248-008-9042-7","article-title":"In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug\u2013Drug Interactions","volume":"10","author":"S Fowler","year":"2008","journal-title":"AAPS J"},{"issue":"1","key":"pcbi.1009053.ref015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/bib\/bbv020","article-title":"A survey of current trends in computational drug repositioning","volume":"17","author":"J Li","year":"2015","journal-title":"Briefings in Bioinformatics"},{"key":"pcbi.1009053.ref016","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13321-015-0055-9","article-title":"Systems biology approaches for advancing the discovery of effective drug combinations","volume":"7","author":"K Ryall","year":"2015","journal-title":"Journal of cheminformatics"},{"issue":"2","key":"pcbi.1009053.ref017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2125.2003.01968.x","article-title":"Application of data mining techniques in pharmacovigilance","volume":"57","author":"AM Wilson","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"pcbi.1009053.ref018","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s40264-015-0352-2","article-title":"Feasibility of Prioritizing Drug-Drug-Event Associations Found in Electronic Health Records","volume":"39","author":"J Banda","year":"2016","journal-title":"Drug Safety"},{"issue":"1","key":"pcbi.1009053.ref019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pds.668","article-title":"A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions","volume":"11","author":"EP van Puijenbroek","year":"2002","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"5","key":"pcbi.1009053.ref020","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/bib\/bbx010","article-title":"Detection of drug\u2013drug interactions through data mining studies using clinical sources, scientific literature and social media","volume":"19","author":"S Vilar","year":"2017","journal-title":"Briefings in Bioinformatics"},{"key":"pcbi.1009053.ref021","volume-title":"Data Mining at FDA","author":"H Duggirala","year":"2018"},{"issue":"3","key":"pcbi.1009053.ref022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/00031305.1999.10474456","article-title":"Bayesian Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System","volume":"53","author":"W Dumouchel","year":"1999","journal-title":"The American Statistician"},{"key":"pcbi.1009053.ref023","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780199694587.001.0001","article-title":"Bayesian Methods in Pharmacovigilance","author":"J Bernardo","year":"2011","journal-title":"Bayesian Statistics 9"},{"key":"pcbi.1009053.ref024","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002280050466","article-title":"A Bayesian neural network method for adverse drug reaction signal generation. European Journal of Clinical Pharmacology, 54, 315-321","volume":"54","author":"A Bate","year":"1998","journal-title":"European journal of clinical pharmacology"},{"key":"pcbi.1009053.ref025","doi-asserted-by":"crossref","DOI":"10.1038\/clpt.2013.24","article-title":"Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System","volume":"93","author":"R Harpaz","year":"2013","journal-title":"Clinical pharmacology and therapeutics"},{"key":"pcbi.1009053.ref026","article-title":"Predicting Adverse Drug-Drug Interactions with Neural Embedding of Semantic Predications","author":"HA Burkhardt","year":"2019","journal-title":"bioRxiv"},{"issue":"13","key":"pcbi.1009053.ref027","doi-asserted-by":"crossref","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","article-title":"Modeling polypharmacy side effects with graph convolutional networks","volume":"34","author":"M Zitnik","year":"2018","journal-title":"Bioinformatics"},{"issue":"18","key":"pcbi.1009053.ref028","doi-asserted-by":"crossref","first-page":"E4304","DOI":"10.1073\/pnas.1803294115","article-title":"Deep learning improves prediction of drug\u2013drug and drug\u2013food interactions","volume":"115","author":"JY Ryu","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1009053.ref029","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/sim.1157","article-title":"On the assessment of adverse drug reactions from spontaneous reporting systems: The influence of under-reporting on odds ratios","volume":"21","author":"PGM Heijden","year":"2002","journal-title":"Statistics in medicine"},{"issue":"2","key":"pcbi.1009053.ref030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001388","article-title":"Use of Non-Steroidal Anti-Inflammatory Drugs That Elevate Cardiovascular Risk: An Examination of Sales and Essential Medicines Lists in Low-, Middle-, and High-Income Countries","volume":"10","author":"P McGettigan","year":"2013","journal-title":"PLOS Medicine"},{"key":"pcbi.1009053.ref031","first-page":"1","article-title":"\u201cBlack Box\u201d to \u201cConversational\u201d Machine Learning: Ondansetron Reduces Risk of Hospital-Acquired Venous Thromboembolism","author":"A Datta","year":"2020","journal-title":"IEEE Journal of Biomedical and Health Informatics"},{"issue":"125","key":"pcbi.1009053.ref032","doi-asserted-by":"crossref","first-page":"125ra31","DOI":"10.1126\/scitranslmed.3003377","article-title":"Data-Driven Prediction of Drug Effects and Interactions","volume":"4","author":"NP Tatonetti","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"12","key":"pcbi.1009053.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1002823","article-title":"Chapter 13: Mining Electronic Health Records in the Genomics Era","volume":"8","author":"JC Denny","year":"2012","journal-title":"PLOS Computational Biology"},{"issue":"4","key":"pcbi.1009053.ref034","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cld.2013.07.002","article-title":"Mechanisms of Drug-induced Liver Injury","volume":"17","author":"L Yuan","year":"2013","journal-title":"Clinics in Liver Disease"},{"issue":"3","key":"pcbi.1009053.ref035","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/hep.21095","article-title":"Drug-induced liver injury: Summary of a single topic clinical research conference","volume":"43","author":"PB Watkins","year":"2006","journal-title":"Hepatology"},{"issue":"4","key":"pcbi.1009053.ref036","doi-asserted-by":"crossref","first-page":"238","DOI":"10.4161\/oxim.3.4.13246","article-title":"Deleterious Effects of Reactive Metabolites","volume":"3","author":"SM Attia","year":"2010","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"pcbi.1009053.ref037","article-title":"Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials","author":"P Sriuttha","year":"2018","journal-title":"Int J Hepatol"},{"key":"pcbi.1009053.ref038","volume-title":"Clinical Pharmacy & Therapeutics","author":"C Whittlesea","year":"2018","edition":"6"},{"issue":"3","key":"pcbi.1009053.ref039","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1001\/archinte.1994.00420030117012","article-title":"Acute Liver Injury Associated With Nonsteroidal Anti-inflammatory Drugs and the Role of Risk Factors","volume":"154","author":"LAG Rodr\u00edguez","year":"1994","journal-title":"Arch Intern Med"},{"issue":"45","key":"pcbi.1009053.ref040","doi-asserted-by":"crossref","first-page":"5651","DOI":"10.3748\/wjg.v16.i45.5651","article-title":"Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?","volume":"16","author":"F Bessone","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pcbi.1009053.ref041","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5604\/01.3001.0010.8633","article-title":"Recent Advances in Hepatotoxicity of Non Steroidal Anti-Inflammatory Drugs","volume":"17","author":"L Meunier","year":"2018","journal-title":"Ann Hepatol"},{"key":"pcbi.1009053.ref042","doi-asserted-by":"crossref","first-page":"180273","DOI":"10.1038\/sdata.2018.273","article-title":"Columbia Open Health Data, clinical concept prevalence and co-occurrence from electronic health records","volume":"5","author":"C Ta","year":"2018","journal-title":"Scientific Data"},{"issue":"2","key":"pcbi.1009053.ref043","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.24060","article-title":"Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure","volume":"53","author":"N Khandelwal","year":"2011","journal-title":"Hepatology"},{"issue":"8","key":"pcbi.1009053.ref044","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"MW Russo","year":"2004","journal-title":"Liver Transplantation"},{"issue":"2","key":"pcbi.1009053.ref045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period","volume":"129","author":"RJ Andrade","year":"2005","journal-title":"Gastroenterology"},{"issue":"2","key":"pcbi.1009053.ref046","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/jhep.2002.34857","article-title":"Incidence of drug-induced hepatic injuries: A French population-based study","volume":"36","author":"C Sgro","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"pcbi.1009053.ref047","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2125.2004.02133.x","article-title":"Acute and clinically relevant drug-induced liver injury: a population based case-control study","volume":"58","author":"FJ De Abajo","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"6","key":"pcbi.1009053.ref048","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","article-title":"Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States","volume":"135","author":"N Chalasani","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"pcbi.1009053.ref049","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","article-title":"Drug-Induced Liver Injury","volume":"89","author":"MD Leise","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"pcbi.1009053.ref050","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1365-2036.2006.03117.x","article-title":"Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic","volume":"24","author":"MB De Valle","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"pcbi.1009053.ref051","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study","volume":"148","author":"N Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"3","key":"pcbi.1009053.ref052","first-page":"228","article-title":"Cetirizine-induced hepatotoxicity: case series and review of the literature","volume":"6","author":"A Coskun","year":"2016","journal-title":"Gastroenterology Report"},{"issue":"6","key":"pcbi.1009053.ref053","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cgh.2011.02.019","article-title":"Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury","volume":"9","author":"ES Orman","year":"2011","journal-title":"Clinical Gastroenterology and Hepatology"},{"issue":"2","key":"pcbi.1009053.ref054","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease","volume":"42","author":"E Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"issue":"20","key":"pcbi.1009053.ref055","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1001\/jama.1990.03450200068033","article-title":"Diclofenac-Associated Hepatotoxicity","volume":"264","author":"SM Helfgott","year":"1990","journal-title":"JAMA"},{"issue":"10","key":"pcbi.1009053.ref056","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2007.03307.x","article-title":"Review article: drug hepatotoxicity","volume":"25","author":"CY Chang","year":"2007","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"5","key":"pcbi.1009053.ref057","doi-asserted-by":"crossref","first-page":"W","DOI":"10.7326\/0003-4819-140-5-200403020-00026-w1","article-title":"Metformin Hepatotoxicity","volume":"140","author":"M Deutsch","year":"2004","journal-title":"Ann Intern Med"},{"issue":"5","key":"pcbi.1009053.ref058","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0002-9343(98)00088-6","article-title":"Metformin-induced Acute Hepatitis","volume":"104","author":"MM Babich","year":"1998","journal-title":"The American Journal of Medicine"},{"key":"pcbi.1009053.ref059","first-page":"703","article-title":"Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review","volume":"6","author":"T S","year":"2013","journal-title":"Int J Gen Med"},{"issue":"4","key":"pcbi.1009053.ref060","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-135-4-200108210-00029","article-title":"Hepatocellular Injury in a Patient Receiving Pioglitazone","volume":"135","author":"M K","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"pcbi.1009053.ref061","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1345\/aph.1E072","article-title":"Second-generation thiazolidinediones and hepatotoxicity","volume":"38","author":"M TR","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"3","key":"pcbi.1009053.ref062","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1097\/MPG.0000000000000566","article-title":"Topiramate-Induced Acute Liver Failure in a Pediatric Patient: a Case Report and Review of Literature","volume":"63","author":"MZ T","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"pcbi.1009053.ref063","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/ijp.IJP_414_16","article-title":"Topiramate-induced acute liver injury: A rare adverse effect","volume":"49","author":"A K","year":"2017","journal-title":"Indian J Pharmacol"},{"issue":"12","key":"pcbi.1009053.ref064","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/apt.13642","article-title":"Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity","volume":"43","author":"JQ Yuan","year":"2016","journal-title":"Alimentary Pharmacology & Therapeutics"},{"issue":"7","key":"pcbi.1009053.ref065","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1517\/14656566.8.7.975","article-title":"Esomeprazole: prevention and treatment of NSAID-induced symptoms and ulcers","volume":"8","author":"A Morgner","year":"2007","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"pcbi.1009053.ref066","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00228-004-0761-0","article-title":"Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case\/non-case study from the French Pharmacovigilance system database","volume":"60","author":"F Clinard","year":"2004","journal-title":"European journal of clinical pharmacology"},{"issue":"6","key":"pcbi.1009053.ref067","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0962280206070650","article-title":"Correlation coefficients in medical research: from product moment correlation to the odds ratio","volume":"15","author":"HC Kraemer","year":"2006","journal-title":"Statistical Methods in Medical Research"},{"key":"pcbi.1009053.ref068","unstructured":"Cortes C, Mohri M. Confidence Intervals for the Area under the ROC Curve. In: Proceedings of the 17th International Conference on Neural Information Processing Systems. NIPS\u201904. Cambridge, MA, USA: MIT Press; 2004. p. 305\u2013312."},{"issue":"6","key":"pcbi.1009053.ref069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0129974","article-title":"Improving Detection of Arrhythmia Drug-Drug Interactions in Pharmacovigilance Data through the Implementation of Similarity-Based Modeling","volume":"10","author":"S Vilar","year":"2015","journal-title":"PLOS ONE"},{"issue":"30","key":"pcbi.1009053.ref070","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1002\/sim.8745","article-title":"Extended multi-item gamma Poisson shrinker methods based on the zero-inflated Poisson model for postmarket drug safety surveillance","volume":"39","author":"SJ Heo","year":"2020","journal-title":"Statistics in Medicine"},{"issue":"7","key":"pcbi.1009053.ref071","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1517\/17425255.2011.574613","article-title":"Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity","volume":"7","author":"JA Ag\u00fandez","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"pcbi.1009053.ref072","article-title":"Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam","author":"DA Barnette","year":"2020","journal-title":"Toxicol Lett"},{"issue":"1","key":"pcbi.1009053.ref073","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/004982598239704","article-title":"Metabolism of Meloxicam in human liver involves cytochromes P4502C9 and 3A4","volume":"28","author":"C Chesne","year":"1998","journal-title":"Xenobiotica"},{"issue":"4","key":"pcbi.1009053.ref074","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"M Chen","year":"2016","journal-title":"Drug Discovery Today"},{"issue":"4","key":"pcbi.1009053.ref075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1472-8206.2006.00416.x","article-title":"Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems","volume":"20","author":"M Lapeyre-Mestre","year":"2006","journal-title":"Fund Clin Pharmacol"},{"key":"pcbi.1009053.ref076","unstructured":"Tsang M, Cheng D, Liu Y. Detecting statistical interactions from neural network weights. arXiv preprint arXiv:170504977. 2017;."}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009053","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:24:46Z","timestamp":1725369886000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009053"}},"subtitle":[],"editor":[{"given":"Andrey","family":"Rzhetsky","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":76,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009053","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1009053","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}